Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

INV1044

Diseases
Phomosis
Country
Belgium
Registration Year
2017
Manufacturer
Bayer
No active offers.
Views
4
Reviews
0
Producer
Bayer
Description INV1044
Winter rapeseed seeds INV1044 are a powerful and stable hybrid, distinguished by high adaptability to various climatic conditions and growing regions. This mid-season hybrid features good winter hardiness and drought tolerance, ensuring stable and high yields of 45-50 ц/ha. Due to the presence of the Rlm7 gene, the hybrid exhibits increased resistance to phomopsis, significantly reducing disease risks and helping maintain crop quality.

The INV1044 hybrid has balanced agronomic traits: winter hardiness rated at 7 points, oil content at 8 points, autumn development and flowering onset at 6 points each, plant height at 7 points. It is well-suited for cultivation with minimal soil tillage and demonstrates high suitability for early and late sowing. The recommended seeding rate varies from 400,000 to 550,000 seeds per hectare depending on sowing dates, allowing flexible adaptation of agronomic practices to specific conditions.

Seeds are supplied in bags of 1.5 million, convenient for large-scale agricultural production. Rapeseed INV1044 is recommended for cultivation in forest-steppe and forested regions. Manufacturer — Germany, ensuring high seed quality and compliance with modern agronomic standards. This hybrid is an excellent choice for farmers aiming to achieve stable and high yields with minimal investment in crop care and protection.
Specifications INV1044
Diseases
Phomosis
Phomosis
Type of Rape
Winter rape
Hybrid Type
Simple Linear
Growing Season
120-130 days
Yield Potential
40-50 ц/га
Plant: height
150-160 cm
Number of plants per hectare
400 thousand pcs/ha
500 thousand pcs/ha
Oil Content
40-45%
Country
Belgium
Registration Year
2017
Catalog
Varieties
Technical Crops
Manufacturer
Bayer
Where to buy INV1044
Loading...
Reviews INV1044
0comments
Sort by:Popular first
No comments yet.